Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for severe or critical COVID-19 pneumonia
ChiCTR2000030779Phase 4Recruiting
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of ulinastatin, sponsored by Shanghai Changzheng Hospital. Started Mar 2020; status: recruiting.
02
Drugs
ulinastatin
Beyond the preview
Go deeper on ChiCTR2000030779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030779.